Penumbra, Inc. (PEN)
After hours:
| Previous close | 204.12 |
| Open | 201.88 |
| Bid | 191.73 x 1200 |
| Ask | 0.00 x 900 |
| Day's range | 198.87 - 204.94 |
| 52-week range | 148.00 - 282.11 |
| Volume | |
| Avg. volume | 461,280 |
| Market cap | 7.859B |
| Beta (5Y monthly) | 0.55 |
| PE ratio (TTM) | 595.03 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Penumbra, Inc. to Present at the Baird Global Healthcare Conference
Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Baird Global Healthcare Conference on Tuesday, September 10, 2024.
- PR Newswire
Penumbra, Inc. to Present at the Wells Fargo Healthcare Conference
Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Wells Fargo Healthcare Conference on Wednesday, September 4, 2024.
- PR Newswire
Penumbra, Inc. Announces $200 Million Share Repurchase Authorization
Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today announced that its Board of Directors approved on August 5, 2024 a share repurchase authorization in the amount of up to $200 million, allowing Penumbra to repurchase its common stock from time to time at such prices as it deems appropriate through open market purchases, block transactions, privately negotiated transactions, including accelerated share repurchase transactions, or otherwise. The repurchase authorization e
